|
Volumn 77, Issue 4, 2010, Pages 366-367
|
Improvement of cognition, a potential benefit of anti-TNF therapy in elderly patients with rheumatoid arthritis
|
Author keywords
Cognition; Rheumatoid arthritis; TNF inhibitor
|
Indexed keywords
ADALIMUMAB;
C REACTIVE PROTEIN;
ETANERCEPT;
METHOTREXATE;
PREDNISOLONE;
IMMUNOGLOBULIN G;
TNFR-FC FUSION PROTEIN;
TUMOR NECROSIS FACTOR ALPHA;
TUMOR NECROSIS FACTOR RECEPTOR;
AGED;
BARTHEL INDEX;
CLINICAL ARTICLE;
COGNITION;
COGNITIVE DEFECT;
DAILY LIFE ACTIVITY;
DISEASE ACTIVITY;
ERYTHROCYTE SEDIMENTATION RATE;
FEMALE;
GERIATRIC DEPRESSION SCALE;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
LETTER;
MALE;
MINI MENTAL STATE EXAMINATION;
PHYSICAL ACTIVITY;
RHEUMATOID ARTHRITIS;
ANTAGONISTS AND INHIBITORS;
ARTHRITIS, RHEUMATOID;
CLINICAL TRIAL;
DRUG EFFECTS;
INTELLIGENCE TEST;
PILOT STUDY;
TREATMENT OUTCOME;
AGED;
ARTHRITIS, RHEUMATOID;
COGNITION;
FEMALE;
HUMANS;
IMMUNOGLOBULIN G;
INTELLIGENCE TESTS;
MALE;
PILOT PROJECTS;
RECEPTORS, TUMOR NECROSIS FACTOR;
TREATMENT OUTCOME;
TUMOR NECROSIS FACTOR-ALPHA;
|
EID: 77954623308
PISSN: 1297319X
EISSN: None
Source Type: Journal
DOI: 10.1016/j.jbspin.2010.01.017 Document Type: Letter |
Times cited : (29)
|
References (10)
|